Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01020526 · ClinicalTrials.gov registry record · Phase 4
Pregabalin In Adolescent Patients With Fibromyalgia
A Phase 4 study, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- Completed
- Registry status
- Phase 4
- Development phase
- 63
- Enrollment target
NCT01020526 is a Phase 4 study that has completed, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 63 participants.
The verdict
NCT01020526, a Phase 4 study, has completed, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 63 participants
- Enrollment target
Study Summary
The main purpose of this study is to evaluate the long-term safety of pregabalin in adolescent patients who participated in the previous fibromyalgia study (A0081180) and who wish to recieve open-label pregabalin
Interventions
- DRUG pregabalin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2010-09 |
| Est. Completion | 2015-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01020526
The ClinicalTrials.gov registry entry for NCT01020526 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pregabalin is the first listed.
NCT01020526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01020526 about?
NCT01020526 is a clinical study titled "Pregabalin In Adolescent Patients With Fibromyalgia". The main purpose of this study is to evaluate the long-term safety of pregabalin in adolescent patients who participated in the previous fibromyalgia study (A0081180) and who wish to recieve open-label pregabalin
What is the current status of trial NCT01020526?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 63 participants. The study started on 2010-09. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01020526?
The interventions under investigation include: pregabalin (DRUG).
Who is sponsoring clinical trial NCT01020526?
This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.